François Ghiringhelli
Impact in
- Immunology top 0.05%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- Phagocytosis and Immune Regulation
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 239
- Cancer Immunotherapy and Biomarkers 115
- Colorectal Cancer Treatments and Studies 76
- CAR-T cell therapy research 27
- Immunology 126
- Immune Cell Function and Interaction 69
- Immunotherapy and Immune Responses 57
- Immune cells in cancer 27
- Co-authors
- Lionel Apétoh (69 shared papers)Laurence Zitvogel (42 shared papers)Guido Kroemer (31 shared papers)Sylvain Ladoire (65 shared papers)Cédric Rébé (45 shared papers)François Martin (18 shared papers)Grégoire Mignot (23 shared papers)Antoine Tesnière (12 shared papers)
- Journals
- Journal of Clinical Oncology (56 papers)Annals of Oncology (44 papers)Cancer Research (19 papers)Cancers (18 papers)OncoImmunology (17 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
François Ghiringhelli
437 papers receiving 28.0k citations
François Ghiringhelli's Hit Papers
Peers
Comparison fields: 5 of 151
- Immunology 12.7k
- Oncology 11.7k
- Physiology 961
- Biological Psychiatry 364
- Cancer Research 2.1k
Countries citing papers authored by François Ghiringhelli
This map shows the geographic impact of François Ghiringhelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Ghiringhelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Ghiringhelli more than expected).
Fields of papers citing papers by François Ghiringhelli
This network shows the impact of papers produced by François Ghiringhelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Ghiringhelli. The network helps show where François Ghiringhelli may publish in the future.
Co-authors
The 25 scholars most cited alongside François Ghiringhelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 454 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Calreticulin exposure dictates the immunogenicity of cancer cell death Hit paper breakdown → | 2006 | 2559 |
| 2 | Immunological aspects of cancer chemotherapy Hit paper breakdown → | 2007 | 1323 |
| 3 | Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death Hit paper breakdown → | 2005 | 1231 |
| 4 | Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice Hit paper breakdown → | 2011 | 1111 |
| 5 | 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity Hit paper breakdown → | 2010 | 985 |
| 6 | Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients Hit paper breakdown → | 2006 | 974 |
| 7 | Immunogenic death of colon cancer cells treated with oxaliplatin Hit paper breakdown → | 2009 | 929 |
| 8 | CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative Hit paper breakdown → | 2004 | 708 |
| 9 | Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth Hit paper breakdown → | 2012 | 621 |
| 10 | Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation Hit paper breakdown → | 2005 | 589 |
| 11 | 2008 | 467 | |
| 12 | 2007 | 461 | |
| 13 | 2007 | 390 | |
| 14 | 2010 | 309 | |
| 15 | Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas Hit paper breakdown → | 2017 | 303 |
| 16 | 2015 | 302 | |
| 17 | 2012 | 270 | |
| 18 | 2011 | 267 | |
| 19 | 2018 | 267 | |
| 20 | 2008 | 260 |
About François Ghiringhelli
François Ghiringhelli is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 454 papers that have together received 28.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (115 papers), Colorectal Cancer Treatments and Studies (76 papers), Immune Cell Function and Interaction (69 papers), Immunotherapy and Immune Responses (57 papers), Cancer Genomics and Diagnostics (30 papers), Lung Cancer Treatments and Mutations (28 papers), Immune cells in cancer (27 papers) and CAR-T cell therapy research (27 papers). The work is most often cited by research in Immunology (12.7k citations), Oncology (11.7k citations), Physiology (961 citations), Biological Psychiatry (364 citations) and Cancer Research (2.1k citations). François Ghiringhelli has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Lionel Apétoh, Laurence Zitvogel, Guido Kroemer, Sylvain Ladoire, Cédric Rébé, François Martin, Grégoire Mignot, Antoine Tesnière, Bruno Chauffert and Mélanie Bruchard. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Cancers and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.